SCHEMBL14330539

SCHEMBL14330539

c1ccc2c(-c3c4ccccc4c(-n4c5ccncc5c5c6ccc7cccc8ccc(cc54)c6c87)c4ccccc34)cccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERBB2 P04626 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ AHR P35869 1/20 0.35
▸ TNF P01375 1/20 0.35
▸ GFER P55789 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TOP2A P11388 1/20 0.33
▸ SLC22A12 Q96S37 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ NISCH Q9Y2I1 1/20 0.32
▸ KCNQ3 O43525 1/20 0.31
▸ KCNQ2 O43526 1/20 0.31
▸ IKBKE Q14164 1/20 0.31
▸ TBK1 Q9UHD2 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14330578 0.92 ERBB2 (0.35) ERBB2CYP1A2FYNMAOAACHE
SCHEMBL14330497 0.81 CYP1A2 (0.35) ERBB2CYP1A2FYNMAOAACHE
SCHEMBL14330540 0.80 MAOA (0.40) ERBB2CYP1A2FYNMAOAACHE
SCHEMBL1102857 0.79 TNF (0.43) MAOAACHETNFGFERNPSR1
SCHEMBL14330538 0.78 MAOA (0.44) ERBB2CYP1A2FYNMAOAACHE
SCHEMBL14329639 0.76 TOP2A (0.40) ERBB2CYP1A2FYNMAOAACHE
SCHEMBL14330561 0.75 TNF (0.37) ERBB2CYP1A2FYNMAOAACHE
SCHEMBL14329624 0.74 TOP2A (0.42) CYP1A2MAOAACHETOP2AKDM4E
SCHEMBL16484872 0.74 TNF (0.31) TNF
SCHEMBL14329649 0.73 MAPK10 (0.42) TOP2AALDH1A1RAB9ASMN1; SMN2CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623521-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-01-07 — — US disclosed
US-8623521-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-01-07 — — US disclosed
US-20120326134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed
US-20120326134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120326134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND DDT, DRD1, HTR3D ERBB2 1188/4885CYP1A2 60/4885FYN 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback